Works matching IS 03407004 AND DT 2005 AND VI 54 AND IP 12
Results: 7
A DeImmunized chimeric anti-C3b/iC3b monoclonal antibody enhances rituximab-mediated killing in NHL and CLL cells via complement activation.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 12, p. 1172, doi. 10.1007/s00262-005-0686-1
- By:
- Publication type:
- Article
Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 12, p. 1191, doi. 10.1007/s00262-005-0695-0
- By:
- Publication type:
- Article
Liposome-polycation-DNA (LPD) particle as a carrier and adjuvant for protein-based vaccines: Therapeutic effect against cervical cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 12, p. 1180, doi. 10.1007/s00262-005-0685-2
- By:
- Publication type:
- Article
Regulatory T cells and tumor immunity.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 12, p. 1153, doi. 10.1007/s00262-005-0699-9
- By:
- Publication type:
- Article
CD8 T cells expressing NK associated receptors are increased in melanoma patients and display an effector phenotype.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 12, p. 1162, doi. 10.1007/s00262-005-0682-5
- By:
- Publication type:
- Article
<sup>90</sup>Y Labeling of monoclonal antibody MOv18 and preclinical validation for radioimmunotherapy of human ovarian carcinomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 12, p. 1200, doi. 10.1007/s00262-005-0693-2
- By:
- Publication type:
- Article
A MAGE-1 antigenic peptide recognized by human cytolytic T lymphocytes on HLA-A2 tumor cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 12, p. 1214, doi. 10.1007/s00262-005-0705-2
- By:
- Publication type:
- Article